Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference

Core Insights - Treace Medical Concepts, Inc. is enhancing its market position with new bunion technologies showcased at the 2025 ACFAS Annual Scientific Conference [1][2] - The company aims to improve surgical outcomes for bunion patients through innovative technologies and clinical evidence [2] Company Overview - Treace Medical Concepts focuses on advancing surgical management for bunions and related midfoot deformities, affecting approximately 67 million Americans, with an estimated 1.1 million surgical candidates annually [4] - The company has developed the patented Lapiplasty® 3D Bunion Correction® System, addressing the root cause of bunions through a comprehensive surgical approach [4] New Innovations - The company introduced next-generation technologies including Micro-Lapiplasty™ and Mini-Adductoplasty™, supported by the new SpeedPlate™ MicroQuad™ implant for stable fixation [5] - New minimally invasive osteotomy systems, Nanoplasty™ and Percuplasty™, are designed to enhance surgeon access and reproducibility in procedures [5] - The SpeedMTP™ implant offers a unique fusion option for patients with arthritic great toe joints, combining advanced fixation technology for early weight bearing [5] Personalized Solutions - The IntelliGuide™ PSI platform provides personalized surgical solutions with patient-specific 3D-printed cut guides and anatomic foot models based on CT scans, leading to a new era in bunion and midfoot deformity corrections [5]